Publications by authors named "Anastasiya Kornyeva"
Background: Lung transplantation (LTx) remains the only efficient treatment for selected patients with end-stage pulmonary disease. The age limit for the acceptance of donor organs in LTx is still a matter of debate. We here analyze the impact of donor organ age and the underlying pulmonary disease on short- and long-term outcome and survival after LTx.
View Article and Find Full Text PDFArticle Synopsis
- Lung transplantation (LTx) is the only effective treatment for patients with end-stage lung disease, and this study examines the safety of pretransplant endoscopic lung volume reduction (eLVR) in patients with emphysema.
- Among 82 patients, those who underwent eLVR were older but showed similar survival rates and postoperative complications compared to those who did not have the procedure prior to double-LTx.
- The findings suggest that eLVR does not increase the risk of postoperative pulmonary complications or negatively impact long-term survival, thereby indicating its potential as a bridge treatment for LTx.
Background: Clinical consequences of prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) is currently in the focus of clinical research. Patients with small aortic annulus are at higher risk to display PPM. Data on incidence and clinical consequences of PPM after TAVR with either balloon-expandable (BEV) or self-expanding (SEV) transcatheter heart valves in small aortic annulus are sparse.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates how total anomalous pulmonary venous connection (TAPVC) affects survival rates in patients with a functional single ventricle undergoing staged palliation, finding that TAPVC significantly increases the risk of mortality during the first stage of treatment.
- Out of 602 patients analyzed, 39 (6.5%) had TAPVC, and the 30-day mortality rate for these patients post-stage 1 palliation was 43.6%, compared to 16.3% for those without TAPVC.
- Although procedures later in the treatment process showed similar survival rates between TAPVC and non-TAPVC patients, pulmonary venous obstruction was identified as an independent risk factor for increased
Non-robotic minimally invasive mitral valve repair: a 20-year single-centre experience.
Eur J Cardiothorac Surg
October 2022
Objectives: Minimally invasive mitral valve repair (MVR) promises major advantages over median sternotomy regarding cosmetic results and faster recovery. However, the long-term functional outcome of minimally invasive MVR has been questioned by critics because the limited access may not exclusively promise high-quality repair. This study examines the long-term outcome regarding survival and reoperation rate.
View Article and Find Full Text PDF